INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 145 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,736,752 | -20.4% | 848,800 | -52.5% | 0.37% | -13.6% |
| Q2 2023 | $19,780,312 | +12596.9% | 1,788,455 | +15317.7% | 0.43% | +14333.3% |
| Q1 2023 | $155,788 | +8.6% | 11,600 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $143,492 | -97.9% | 11,600 | -97.7% | 0.00% | -98.3% |
| Q3 2022 | $6,956,000 | +725.1% | 498,600 | +716.3% | 0.17% | +690.9% |
| Q2 2022 | $843,000 | -87.2% | 61,079 | -84.9% | 0.02% | -85.8% |
| Q4 2021 | $6,606,000 | +415.3% | 405,494 | +369.9% | 0.16% | +342.9% |
| Q3 2021 | $1,282,000 | -51.3% | 86,300 | +321.0% | 0.04% | -96.5% |
| Q1 2016 | $2,634,000 | – | 20,500 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |